Bnp Paribas Arbitrage Sa Lowered Its York Wtr Co (YORW) Stake; First Foundation Advisors Has Trimmed Its Bristol Myers Squibb Co (BMY) Stake

February 10, 2018 - By Michael Collier

Bnp Paribas Arbitrage Sa decreased York Wtr Co (YORW) stake by 9.57% reported in 2017Q3 SEC filing. Bnp Paribas Arbitrage Sa sold 143 shares as York Wtr Co (YORW)’s stock declined 7.75%. The Bnp Paribas Arbitrage Sa holds 1,351 shares with $45.80M value, down from 1,494 last quarter. York Wtr Co now has $390.96M valuation. The stock increased 3.40% or $1 during the last trading session, reaching $30.4. About 25,153 shares traded. The York Water Company (NASDAQ:YORW) has risen 17.68% since February 10, 2017 and is uptrending. It has outperformed by 0.98% the S&P500.

First Foundation Advisors decreased Bristol Myers Squibb Co (BMY) stake by 36.74% reported in 2017Q3 SEC filing. First Foundation Advisors sold 17,706 shares as Bristol Myers Squibb Co (BMY)’s stock declined 1.04%. The First Foundation Advisors holds 30,482 shares with $1.94 million value, down from 48,188 last quarter. Bristol Myers Squibb Co now has $102.62 billion valuation. The stock increased 0.02% or $0.01 during the last trading session, reaching $62.7. About 11.16 million shares traded or 68.05% up from the average. Bristol-Myers Squibb Company (NYSE:BMY) has declined 23.19% since February 10, 2017 and is downtrending. It has underperformed by 39.89% the S&P500.

First Foundation Advisors increased Chevron Corp (NYSE:CVX) stake by 4,684 shares to 21,977 valued at $2.58M in 2017Q3. It also upped Nuveen Quality Municipal Incom (NAD) stake by 32,795 shares and now owns 64,465 shares. Molson Coors Brewing Co (NYSE:TAP) was raised too.

Among 19 analysts covering Bristol-Myers Squibb Company (NYSE:BMY), 6 have Buy rating, 3 Sell and 10 Hold. Therefore 32% are positive. Bristol-Myers Squibb Company had 71 analyst reports since July 28, 2015 according to SRatingsIntel. The rating was maintained by Barclays Capital with “Equal-Weight” on Friday, September 9. SunTrust maintained it with “Hold” rating and $55.0 target in Monday, October 16 report. The rating was maintained by UBS with “Buy” on Friday, August 19. The firm has “Buy” rating by UBS given on Friday, October 6. The rating was maintained by Citigroup on Wednesday, October 25 with “Buy”. The firm earned “Buy” rating on Wednesday, August 23 by Jefferies. Leerink Swann maintained the stock with “Buy” rating in Tuesday, February 6 report. The firm has “Underperform” rating by BMO Capital Markets given on Friday, July 28. The rating was downgraded by Morgan Stanley on Friday, August 5 to “Equal-Weight”. As per Friday, January 22, the company rating was upgraded by Berenberg.

Investors sentiment increased to 1.03 in 2017 Q3. Its up 0.08, from 0.95 in 2017Q2. It increased, as 62 investors sold BMY shares while 519 reduced holdings. 137 funds opened positions while 460 raised stakes. 1.11 billion shares or 0.68% more from 1.10 billion shares in 2017Q2 were reported. Dubuque Commercial Bank has 9,619 shares for 0.1% of their portfolio. Macnealy Hoover Investment Management holds 0.79% of its portfolio in Bristol-Myers Squibb Company (NYSE:BMY) for 17,290 shares. Glg owns 169,273 shares. Edgemoor Inv Advsrs Incorporated reported 0.03% stake. United Commercial Bank Va invested in 6,812 shares or 0.41% of the stock. Sterling Mngmt Ltd Liability Company owns 980,911 shares for 0.59% of their portfolio. New York-based Van Eck Associates Corporation has invested 0.26% in Bristol-Myers Squibb Company (NYSE:BMY). Capital Invest Advsr Ltd Company reported 45,655 shares. Cap Counsel has 0.11% invested in Bristol-Myers Squibb Company (NYSE:BMY). First State Bank Of Omaha holds 0.06% of its portfolio in Bristol-Myers Squibb Company (NYSE:BMY) for 16,364 shares. Commonwealth Of Pennsylvania Public School Empls Retrmt holds 0.13% or 133,370 shares in its portfolio. Azimuth Capital Management Limited Liability Company reported 0.59% stake. Meristem Limited Liability Partnership holds 13,723 shares. 28,237 were accumulated by Monarch Management. Hillsdale Investment Mgmt holds 0.06% or 5,840 shares in its portfolio.

Since September 6, 2017, it had 1 buy, and 2 selling transactions for $646,385 activity. $560,400 worth of Bristol-Myers Squibb Company (NYSE:BMY) was sold by Caldarella Joseph C. Shares for $335,172 were sold by Lynch Thomas J. Jr. on Tuesday, December 12. $249,187 worth of stock was bought by Samuels Theodore R. II on Friday, December 15.

Investors sentiment increased to 1.37 in 2017 Q3. Its up 0.09, from 1.28 in 2017Q2. It improved, as 5 investors sold YORW shares while 22 reduced holdings. 10 funds opened positions while 27 raised stakes. 4.31 million shares or 4.81% less from 4.53 million shares in 2017Q2 were reported. 129,114 were accumulated by Geode Cap Mgmt Ltd Com. Parametric Port Assoc Ltd Company holds 19,086 shares or 0% of its portfolio. Nationwide Fund Advsr reported 7,037 shares. California State Teachers Retirement has 20,379 shares. Pnc Group Inc holds 23,000 shares. Ameritas Inv Partners reported 992 shares stake. Teton Advsr, New York-based fund reported 44,037 shares. Millennium Limited reported 0% of its portfolio in The York Water Company (NASDAQ:YORW). Los Angeles Cap Mgmt And Equity Rech stated it has 7,905 shares. Arcadia Invest Corporation Mi accumulated 0.03% or 2,432 shares. Moreover, Bb&T has 0% invested in The York Water Company (NASDAQ:YORW) for 6,440 shares. Moreover, Thrivent Financial For Lutherans has 0% invested in The York Water Company (NASDAQ:YORW). Bridgeway Capital Inc invested in 30,364 shares or 0.01% of the stock. Goldman Sachs Gp has 16,155 shares for 0% of their portfolio. Manchester Cap Mgmt Ltd Company invested 0.12% in The York Water Company (NASDAQ:YORW).

Bnp Paribas Arbitrage Sa increased Inter Parfums Inc (NASDAQ:IPAR) stake by 2,906 shares to 9,639 valued at $397.61 million in 2017Q3. It also upped Healthcare Tr Amer Inc (NYSE:HTA) stake by 111,726 shares and now owns 174,959 shares. Thor Inds Inc (NYSE:THO) was raised too.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.





Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: